150 related articles for article (PubMed ID: 22171616)
41. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S
Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849
[TBL] [Abstract][Full Text] [Related]
42. PEG-templated mesoporous silica nanoparticles exclusively target cancer cells.
Morelli C; Maris P; Sisci D; Perrotta E; Brunelli E; Perrotta I; Panno ML; Tagarelli A; Versace C; Casula MF; Testa F; Andò S; Nagy JB; Pasqua L
Nanoscale; 2011 Aug; 3(8):3198-207. PubMed ID: 21725561
[TBL] [Abstract][Full Text] [Related]
43. Effects of the antifolates pemetrexed and CB3717 on the tissue distribution of (99m)Tc-EC20 in xenografted and syngeneic tumor-bearing mice.
Müller C; Reddy JA; Leamon CP; Schibli R
Mol Pharm; 2010 Apr; 7(2):597-604. PubMed ID: 20199053
[TBL] [Abstract][Full Text] [Related]
44. Increased uptake of folate conjugates by activated macrophages in experimental hyperlipemia.
Antohe F; Radulescu L; Puchianu E; Kennedy MD; Low PS; Simionescu M
Cell Tissue Res; 2005 May; 320(2):277-85. PubMed ID: 15714274
[TBL] [Abstract][Full Text] [Related]
45. Development of a fluorescence polarization binding assay for folate receptor.
Kornilova AY; Algayer B; Breslin M; Addona GH; Uebele V
Anal Biochem; 2013 Jan; 432(2):59-62. PubMed ID: 23022041
[TBL] [Abstract][Full Text] [Related]
46. Folate-mediated tumor cell uptake of quantum dots entrapped in lipid nanoparticles.
Schroeder JE; Shweky I; Shmeeda H; Banin U; Gabizon A
J Control Release; 2007 Dec; 124(1-2):28-34. PubMed ID: 17928088
[TBL] [Abstract][Full Text] [Related]
47. Folate receptor-targeted liposomes as possible delivery vehicles for boron neutron capture therapy.
Stephenson SM; Yang W; Stevens PJ; Tjarks W; Barth RF; Lee RJ
Anticancer Res; 2003; 23(4):3341-5. PubMed ID: 12926073
[TBL] [Abstract][Full Text] [Related]
48. In vivo antitumor activity of the folate-conjugated pH-sensitive polymeric micelle selectively releasing adriamycin in the intracellular acidic compartments.
Bae Y; Nishiyama N; Kataoka K
Bioconjug Chem; 2007; 18(4):1131-9. PubMed ID: 17488066
[TBL] [Abstract][Full Text] [Related]
49. Indium-111-DTPA-folate as a potential folate-receptor-targeted radiopharmaceutical.
Mathias CJ; Wang S; Waters DJ; Turek JJ; Low PS; Green MA
J Nucl Med; 1998 Sep; 39(9):1579-85. PubMed ID: 9744347
[TBL] [Abstract][Full Text] [Related]
50. Higher liposomal membrane fluidity enhances the in vitro antitumor activity of folate-targeted liposomal mitoxantrone.
Kawano K; Onose E; Hattori Y; Maitani Y
Mol Pharm; 2009; 6(1):98-104. PubMed ID: 19072653
[TBL] [Abstract][Full Text] [Related]
51. Design and synthesis of releasable folate-drug conjugates using a novel heterobifunctional disulfide-containing linker.
Satyam A
Bioorg Med Chem Lett; 2008 Jun; 18(11):3196-9. PubMed ID: 18468892
[TBL] [Abstract][Full Text] [Related]
52. Enhancing the therapeutic range of a targeted small-molecule tubulysin conjugate for folate receptor-based cancer therapy.
Leamon CP; Reddy JA; Vlahov IR; Dorton R; Bloomfield A; Vetzel M; Klein PJ; Westrick E; Xu LC; Wang Y
Cancer Chemother Pharmacol; 2017 Jun; 79(6):1151-1160. PubMed ID: 28451831
[TBL] [Abstract][Full Text] [Related]
53. Sensitive fluorescence biosensor for folate receptor based on terminal protection of small-molecule-linked DNA.
Wei X; Lin W; Ma N; Luo F; Lin Z; Guo L; Qiu B; Chen G
Chem Commun (Camb); 2012 Jun; 48(49):6184-6. PubMed ID: 22590712
[TBL] [Abstract][Full Text] [Related]
54. Targeting the Folate Receptor: Improving Efficacy in Inorganic Medicinal Chemistry.
Carron PM; Crowley A; O'Shea D; McCann M; Howe O; Hunt M; Devereux M
Curr Med Chem; 2018; 25(23):2675-2708. PubMed ID: 29424300
[TBL] [Abstract][Full Text] [Related]
55. Uptake and trafficking of fluorescent conjugates of folic acid in intact kidney determined using intravital two-photon microscopy.
Sandoval RM; Kennedy MD; Low PS; Molitoris BA
Am J Physiol Cell Physiol; 2004 Aug; 287(2):C517-26. PubMed ID: 15102609
[TBL] [Abstract][Full Text] [Related]
56. Acute ethanol exposure inhibits renal folate transport, but repeated exposure upregulates folate transport proteins in rats and human cells.
Romanoff RL; Ross DM; McMartin KE
J Nutr; 2007 May; 137(5):1260-5. PubMed ID: 17449590
[TBL] [Abstract][Full Text] [Related]
57. Reducing undesirable hepatic clearance of a tumor-targeted vinca alkaloid via novel saccharopeptidic modifications.
Leamon CP; Reddy JA; Klein PJ; Vlahov IR; Dorton R; Bloomfield A; Nelson M; Westrick E; Parker N; Bruna K; Vetzel M; Gehrke M; Nicoson JS; Messmann RA; LoRusso PM; Sausville EA
J Pharmacol Exp Ther; 2011 Feb; 336(2):336-43. PubMed ID: 20978169
[TBL] [Abstract][Full Text] [Related]
58. Tumor detection using folate receptor-targeted imaging agents.
Sega EI; Low PS
Cancer Metastasis Rev; 2008 Dec; 27(4):655-64. PubMed ID: 18523731
[TBL] [Abstract][Full Text] [Related]
59. Folate targeting enables durable and specific antitumor responses from a therapeutically null tubulysin B analogue.
Leamon CP; Reddy JA; Vetzel M; Dorton R; Westrick E; Parker N; Wang Y; Vlahov I
Cancer Res; 2008 Dec; 68(23):9839-44. PubMed ID: 19047164
[TBL] [Abstract][Full Text] [Related]
60. In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice.
Gabizon A; Horowitz AT; Goren D; Tzemach D; Shmeeda H; Zalipsky S
Clin Cancer Res; 2003 Dec; 9(17):6551-9. PubMed ID: 14695160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
